Health Care Equipment & Supplies · NYSE
SOLVSolventum Corp
- Last close
- $89.08 +0.3%
- 52-week range
- $62.38 to $94.16
- Market cap
- $15.1B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Stock price
Valuation vs its own history since 2024
Above its median since 2024 on all 3 multiples
Where each multiple sits today inside its own range since 2024, measured at every quarter end. The thin tick is the median.
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.
Valuation
- P/E
- 100x
- Earnings yield
- 1.0%
- Price / sales
- 1.9x
- Price / book
- 3.1x
- Price / operating cash flow
- 48.8x
- EV / EBITDA
- 20.2x
- EV / sales
- 2.4x
- Free cash flow yield
- 0.00%
Profitability
- Gross margin
- 54.8%
- Operating margin
- 5.6%
- Net margin
- 1.9%
- Return on equity
- 3.2%
- Return on capital
- 4.2%
Growth per year
- Revenue, 3 years
- +0.8%
- Revenue, 5 years
- n/aLess than 5 years of history
- EPS, 3 years
- +4.5%
Balance sheet
- Cash and investments
- $451M
- Total debt
- $5.07B
- Net cash
- -$4.62B
- Debt / equity
- 1.05x
- Current ratio
- 1.03x
Shares and dividend
- Shares outstanding
- 170M
- Share count, 5 years
- n/aLess than 5 years of history
- Beta, 1 year
- 0.57
- Dividend yield
- n/a
- Dividend per share, TTM
- n/a
- Payout ratio
- n/a
n/a: No dividend
Every year we have of the business
Last 15 quarters, fiscal 2022 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2022 to 2025.
Where the revenue comes from
Product went from 77% to 76% of revenue in 3 years
Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.
| Product line | Revenue | Share | vs FY24 |
|---|---|---|---|
| Product | $6.35B | 76.3% | +0% |
| Cost of Software and Rentals | $1.98B | 23.7% | +4% |
Health Care Equipment & Supplies peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | $188B | +10% | 13.8% | 40.4x | 3.9x | 60th percentile |
| DHR Danaher Corp | $164B | +6% | 20.4% | 38.1x | 6.4x | 65th percentile |
| ISRG Intuitive Surgical Inc | $154B | +20% | 28.4% | 53.7x | 13.3x | 48th percentile |
| MDT Medtronic plc | $132B | +10% | 18.1% | 25.3x | 3.5x | 20th percentile |
| SYK Stryker Corp | $118B | +8% | 20.7% | 33.0x | 4.5x | 30th percentile |
| SOLV Solventum Corp | $15.1B | -3% | 5.6% | 100x | 1.9x | Highest in its range |
The company
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- CEO
- http://www.wikidata.org/.well-known/genid/14d80a4ed0ecf85d7dd88c588fe5e248
- Employees
- 20,000 (as of 2025)
- Founded
- 2024
- Headquarters
- Eagan, MN
- Fiscal year ends
- December
- Website
- solventum.com
What it does
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
Description from Wikipedia (CC BY-SA).
Around the numbers
What the rest of EdgeStacker knows about SOLV.